3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Motor Activity
35
Breast Neoplasms
19
Neoplasms
18
Fatigue
9
Prostatic Neoplasms
4
Lung Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Obesity
3
Weight Loss
2
Smoking
2
Sedentary Behavior
2
Postoperative Complications
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Mixed Cancer
2
Lymphedema
2
Frailty
2
Colonic Neoplasms
2
Cardiotoxicity
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Urinary Incontinence
1
Stomach Neoplasms
1
Sarcoma
1
Risk Reduction Behavior
1
Interventions
Radiotherapy
3
Cisplatin
2
sapropterin
1
pembrolizumab
1
fludarabine
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Sentinel Lymph Node Biopsy
1
Ritonavir
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Mindfulness
1
Indinavir
1
Gene Rearrangement
1
Gene Expression Profiling
1
Gemcitabine
1
Exercise
1
Electrochemotherapy
1
Drug Therapy
1
Cyclophosphamide
1
Bleomycin
1
Amplified Fragment Length Polymorphism Analysis
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Vulvar Neoplasms
×
Exercise
×
Clear all
NCT05561413
2022-10-03
GEMS
University of Ulster
Phase NA
Unknown
40 enrolled